Who owns Spero Therapeutics Inc?
- Ticker: SPRO
- CUSIP Number: 84833t103
Tip: Access positions for across all investors
Analyze quarterly positions in Spero Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Spero Therapeutics stock
Who bought or sold Spero Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Pfizer | 2.4M | $5.5M | 0% | Mar 2026 |
|
| Vanguard Group | 2.1M | $4.9M | 5% | Dec 2025 |
|
| Vanguard Capital Management | 1.8M | $4.2M | 100% | Mar 2026 |
|
| Renaissance Technologies | 1.3M | $3.0M | -12% | Dec 2025 |
|
| Alphabet | 890k | $2.1M | 0% | Mar 2026 |
|
| Two Sigma Investments | 886k | $2.1M | 138% | Mar 2026 |
|
| Geode Capital Management | 520k | $1.2M | -2% | Mar 2026 |
|
| BlackRock | 433k | $1.0M | 0% | Mar 2026 |
|
| Citadel Advisors | 426k | $996k | -10% | Mar 2026 |
|
| Frigate Ventures | 422k | $987k | -32% | Mar 2026 |
|
| Susquehanna International | 294k | $684k | 2594% | Dec 2025 |
|
| GSA Capital Partners | 278k | $651k | 56% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 264k | $618k | 100% | Mar 2026 |
|
| State Street Corporation | 210k | $490k | 10% | Dec 2025 |
|
| Ionic Capital Management | 196k | $459k | 0% | Mar 2026 |
|
| Squarepoint Ops | 194k | $455k | 63% | Mar 2026 |
|
| Jane Street | 183k | $427k | -7% | Mar 2026 |
|
| Intrepid Family Office | 165k | $385k | 50% | Dec 2025 |
|
| Northern Trust | 121k | $282k | -7% | Dec 2025 |
|
| Bridgeway Capital Management | 115k | $268k | 0% | Dec 2025 |
|
| Shay Capital | 70k | $165k | 100% | Mar 2026 |
|
| Point72 Asset Management | 60k | $140k | 37% | Mar 2026 |
|
| Invesco | 45k | $106k | 84% | Mar 2026 |
|
| OMERS Administration Corporation | 39k | $92k | -70% | Mar 2026 |
|
| Quadrature Capital | 38k | $88k | 100% | Dec 2025 |
|
| Simplex Trading | 36k | $83k | 368% | Dec 2025 |
|
| Capital Asset Advisory Services | 33k | $92k | 0% | Mar 2026 |
|
| Three Seasons Wealth | 30k | $70k | 0% | Mar 2026 |
|
| Dimensional Fund Advisors | 30k | $70k | 0% | Mar 2026 |
|
| Charles Schwab Investment Management | 29k | $67k | 0% | Dec 2025 |
|
| Vanguard Global Advisers | 25k | $60k | 100% | Mar 2026 |
|
| Schonfeld Strategic Advisors | 20k | $48k | 100% | Mar 2026 |
|
| Citigroup | 19k | $45k | 100% | Mar 2026 |
|
| Assenagon Asset Management | 19k | $44k | 0% | Mar 2026 |
|
| Torrey Growth & Income Advisors | 17k | $38k | 100% | Mar 2026 |
|
| Occudo Quantitative Strategies | 16k | $41k | 100% | Mar 2026 |
|
| XTX Topco | 15k | $35k | -55% | Dec 2025 |
|
| Tower Research Capital | 7.2k | $17k | 100% | Dec 2025 |
|
| Jones Financial Companies, L.L | 6.5k | $15k | 100% | Dec 2025 |
|
| FNY Investment Advisers | 5.3k | $12k | 0% | Mar 2026 |
|
| Morgan Stanley | 4.6k | $11k | 1354% | Mar 2026 |
|
| UBS Group | 3.0k | $7.0k | -97% | Mar 2026 |
|
| Advisor Group Holdings | 290.00 | $675.004000 | 0% | Dec 2025 |
|
| Wells Fargo & Company | 200.00 | $468.000000 | 0% | Mar 2026 |
|
| Us Bancorp | 151.00 | $351.996100 | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 40.00 | $94.000000 | 0% | Mar 2026 |
|
| SageView Advisory Group | 17.00 | $39.999300 | 100% | Dec 2025 |
|
| Farther Finance Advisors | 10.00 | $25.000000 | 0% | Mar 2026 |
|
| SBI Securities | 9.00 | $20.999700 | 0% | Mar 2026 |
|
| Caitong International Asset Management | 3.00 | $6.999900 | 100% | Mar 2026 |
|
Who sold out of Spero Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Eudaimonia Asset Management | Dec 2025 | 218k | $508k |
| Two Sigma Advisers | Dec 2025 | 217k | $505k |
| Arrowstreet Capital, Limited Partnership | Sep 2025 | 151k | $283k |
| Sei Investments | Dec 2025 | 132k | $0 |
| ADAR1 Capital Management | Dec 2025 | 114k | $265k |
| None | Dec 2025 | 60k | $141k |
| American Century Companies | Sep 2025 | 40k | $76k |
| Axxcess Wealth Management | Dec 2025 | 33k | $76k |
| Millennium Management | Dec 2025 | 24k | $56k |
| Yale Capital Corp. | Dec 2025 | 10k | $23k |
| Cullen Frost Bankers | Dec 2025 | 3.0k | $7.0k |
| FMR | Sep 2025 | 550.00 | $1.0k |
| Jpmorgan Chase & Co | Sep 2025 | 236.00 | $444.010400 |
| Rockefeller Capital Management | Dec 2025 | 200.00 | $466.000000 |